Physician
Pahlavan, Peyman
Pahlavan, Peyman was paid $5.55M by Medicaid between Jan 2018 and Dec 2024, across 96 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 38% of everything it billed.
33Billing provider infoPAHLAVAN, PEYMAN
MELROSE PARK, IL 60160
MELROSE PARK, IL 60160
33aNPI1063450757assigned 06/03/2006
33bProvider typeGeriatric Medicine (Internal Medicine) Physician
28Total paid$5.55M
24GClaims174,658
24DCodes billed96
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Geriatric Medicine (Internal Medicine) Physician providers in Illinois
Rank by total paid#1 of 65
Median peer was paid$13K
This provider vs. median417×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,091 | $228K | |
| 2019 | 16,630 | $453K | |
| 2020 | 28,414 | $802K | |
| 2021 | 32,654 | $958K | |
| 2022 | 29,503 | $1.03M | |
| 2023 | 29,873 | $1.08M | |
| 2024incomplete | 27,493 | $1.00M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 38% | 29,383 | 22,944 | $2.10M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 21,430 | 15,344 | $984K |
| 95144 | 5.2% | 1,039 | 166 | $287K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 4.0% | 2,918 | 2,150 | $224K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 3.8% | 2,733 | 2,061 | $211K |
| 96136 | 2.5% | 4,142 | 3,186 | $137K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.8% | 8,739 | 7,457 | $101K |
| 90636 | 1.8% | 990 | 800 | $100K | |
| 90750 | 1.8% | 662 | 502 | $99K | |
| 99385 | 1.7% | 1,054 | 763 | $96K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.5% | 5,453 | 4,409 | $85K |
| 93000 | <1% | 2,841 | 2,291 | $55K |
84 more codes
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 721 | $54K |
| 96127 | <1% | 3,588 | $52K | |
| 99386 | <1% | 562 | $50K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,263 | $44K |
| 95250 | <1% | 531 | $41K | |
| 0001A | <1% | 955 | $40K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 985 | $40K |
| 0002A | <1% | 929 | $39K | |
| 90756 | <1% | 1,373 | $38K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,251 | $38K |
| 81003 | <1% | 18,209 | $38K | |
| 81025 | <1% | 8,007 | $37K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 363 | $34K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,512 | $31K |
| 82962 | <1% | 16,363 | $31K | |
| 90688 | <1% | 1,723 | $30K | |
| 0012A | <1% | 714 | $30K | |
| 0011A | <1% | 764 | $30K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 679 | $28K |
| 90677 | <1% | 119 | $26K | |
| 90715 | <1% | 734 | $22K | |
| 80305 | <1% | 2,493 | $22K | |
| 91320 | <1% | 186 | $21K | |
| 90662 | <1% | 333 | $18K | |
| 0064A | <1% | 373 | $18K | |
| 0124A | <1% | 350 | $15K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 268 | $14K |
| 99406 | <1% | 2,875 | $14K | |
| 95923 | <1% | 173 | $14K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 323 | $13K |
| 0004A | <1% | 275 | $11K | |
| 99397 | <1% | 136 | $11K | |
| 95921 | <1% | 164 | $9K | |
| 90694 | <1% | 135 | $9K | |
| 93922 | <1% | 171 | $8K | |
| 0134A | <1% | 219 | $8K | |
| 90682 | <1% | 152 | $8K | |
| 90707 | <1% | 104 | $7K | |
| 82947 | <1% | 1,970 | $7K | |
| 81002 | <1% | 3,084 | $7K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 115 | $7K |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 3,409 | $6K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 252 | $6K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 305 | $4K |
| 94760 | <1% | 1,046 | $4K | |
| 99490 | Ccm add 20min | <1% | 306 | $3K |
| 0003A | <1% | 80 | $3K | |
| 0071A | <1% | 69 | $3K | |
| 69209 | <1% | 305 | $3K | |
| 36416 | <1% | 1,401 | $3K | |
| 0013A | <1% | 57 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,816 | $2K |
| 0072A | <1% | 51 | $2K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 27 | $2K |
| 20610 | <1% | 54 | $2K | |
| 90480 | <1% | 46 | $2K | |
| 90686 | <1% | 185 | $2K | |
| 86328 | <1% | 25 | $1K | |
| 92540 | <1% | 23 | $1K | |
| 92546 | <1% | 62 | $893.49 | |
| 86580 | <1% | 192 | $867.70 | |
| 95251 | <1% | 34 | $684.80 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 13 | $667.03 |
| 85018 | <1% | 197 | $450.82 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 249 | $421.63 |
| J7626 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg | <1% | 245 | $357.60 |
| 99173 | <1% | 83 | $342.70 | |
| 92547 | <1% | 26 | $319.18 | |
| 99072 | <1% | 435 | $313.50 | |
| 85014 | <1% | 123 | $283.04 | |
| 90620 | <1% | 19 | $275.20 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 81 | $99.25 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 216 | $97.08 |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 20 | $67.20 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 85 | $46.23 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 234 | $16.58 |
| 91300 | <1% | 903 | $3.81 | |
| 91301 | <1% | 798 | $3.24 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 314 | $0.45 |
| 91312 | <1% | 113 | $0.11 | |
| 91313 | <1% | 54 | $0.11 | |
| 91306 | <1% | 25 | $0.05 | |
| 91307 | <1% | 36 | $0.03 | |
| 90461 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.